Literature DB >> 25485500

p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.

Sonia Melino1, Alessia Bellomaria, Ridvan Nepravishta, Maurizio Paci, Gerry Melino.   

Abstract

Both in epithelial development as well as in epithelial cancers, the p53 family member p63 plays a crucial role acting as a master transcriptional regulator. P63 steady state protein levels are regulated by the E3 ubiquitin ligase Itch, via a physical interaction between the PPxY consensus sequence (PY motif) of p63 and one of the 4 WW domains of Itch; this substrate recognition process leads to protein-ubiquitylation and p63 proteasomal degradation. The interaction of the WW domains, a highly compact protein-protein binding module, with the short proline-rich sequences is therefore a crucial regulatory event that may offer innovative potential therapeutic opportunity. Previous molecular studies on the Itch-p63 recognition have been performed in vitro using the Itch-WW2 domain and the peptide interacting fragment of p63 (pep63), which includes the PY motif. Itch-WW2-pep63 interaction is also stabilized in vitro by the conformational constriction of the S-S cyclization in the p63 peptide. The PY motif of p63, as also for other proteins, is characterized by the nearby presence of a (T/S)P motif, which is a potential recognition site of the WW domain of the IV group present in the prolyl-isomerase Pin1. In this study, we demonstrate, by in silico and spectroscopical studies using both the linear pep63 and its cyclic form, that the threonine phosphorylation of the (T/S)PPPxY motif may represent a crucial regulatory event of the Itch-mediated p63 ubiquitylation, increasing the Itch-WW domains-p63 recognition event and stabilizing in vivo the Itch-WW-p63 complex. Moreover, our studies confirm that the subsequently trans/cis proline isomerization of (T/S)P motif by the Pin1 prolyl-isomerase, could modulate the E3-ligase interaction, and that the (T/S)pPtransPPxY motif represent the best conformer for the ItchWW-(T/S)PPPxY motif recognition.

Entities:  

Keywords:  CXCR4, chemokine receptor; E3 ubiquitin ligases; HECT, Homologous E6-AP Carboxyl Terminus; IPTG, isopropyl-β-D-thiogalactoside; Itch; Pin1; Ppep63, phosphorylated pep63; RHS, Rapp-Hodgkin syndrome; RP-HPLC, reverse phase high performance chromatography; TFE, 2, 2, 2-trifluoroethanol; TNF, tumor necrosis factor; TRAF6, TNF receptor-associated factor 6; cPpep63, cyclic phosphorylated pep63; p53 family; p63; pep63, p63(534–551) peptide; proline isomerization; ubiquitynation

Mesh:

Substances:

Year:  2014        PMID: 25485500      PMCID: PMC4613134          DOI: 10.4161/15384101.2014.951285

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  117 in total

1.  WW: An isolated three-stranded antiparallel beta-sheet domain that unfolds and refolds reversibly; evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered thermal unfolded state.

Authors:  E K Koepf; H M Petrassi; M Sudol; J W Kelly
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype.

Authors:  Yi-Ping Huang; Guojun Wu; Zhongmin Guo; Motonobu Osada; Tanya Fomenkov; Hannah Lui Park; Barry Trink; David Sidransky; Alexey Fomenkov; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2004-12-07       Impact factor: 4.534

Review 3.  Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins.

Authors:  M Buck
Journal:  Q Rev Biophys       Date:  1998-08       Impact factor: 5.318

4.  Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction.

Authors:  Alessia Bellomaria; Gaetano Barbato; Gerry Melino; Maurizio Paci; Sonia Melino
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

5.  Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.

Authors:  M Schutkowski; A Bernhardt; X Z Zhou; M Shen; U Reimer; J U Rahfeld; K P Lu; G Fischer
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

6.  DeltaNp63alpha up-regulates the Hsp70 gene in human cancer.

Authors:  Guojun Wu; Motonobu Osada; Zhongmin Guo; Alexey Fomenkov; Shahnaz Begum; Ming Zhao; Sunil Upadhyay; Mingzhao Xing; Feng Wu; Chulso Moon; William H Westra; Wayne M Koch; Roberto Mantovani; Joseph A Califano; Edward Ratovitski; David Sidransky; Barry Trink
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

7.  Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.

Authors:  Yiping Huang; Jun Seop Jeong; Jun Okamura; Myoung Sook-Kim; Heng Zhu; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

8.  TAp73 depletion accelerates aging through metabolic dysregulation.

Authors:  Alessandro Rufini; Maria Victoria Niklison-Chirou; Satoshi Inoue; Richard Tomasini; Isaac S Harris; Arianna Marino; Massimo Federici; David Dinsdale; Richard A Knight; Gerry Melino; Tak Wah Mak
Journal:  Genes Dev       Date:  2012-09-15       Impact factor: 11.361

9.  TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses.

Authors:  R Tomasini; V Secq; L Pouyet; A K Thakur; M Wilhelm; J Nigri; S Vasseur; P Berthezene; E Calvo; G Melino; T W Mak; J L Iovanna
Journal:  Cell Death Differ       Date:  2012-09-14       Impact factor: 15.828

Review 10.  p63 the guardian of human reproduction.

Authors:  Ivano Amelio; Francesca Grespi; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

View more
  9 in total

1.  T538 phosphorylation, Pin-ing p63-Itch stability.

Authors:  Akram Alian; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Distinct interactors define the p63 transcriptional signature in epithelial development or cancer.

Authors:  Rosalba Pecorari; Francesca Bernassola; Gerry Melino; Eleonora Candi
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

Review 3.  Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.

Authors:  Vivien Landré; Barak Rotblat; Sonia Melino; Francesca Bernassola; Gerry Melino
Journal:  Oncotarget       Date:  2014-09-30

4.  p73 regulates basal and starvation-induced liver metabolism in vivo.

Authors:  Zhaoyue He; Massimiliano Agostini; He Liu; Gerry Melino; Hans-Uwe Simon
Journal:  Oncotarget       Date:  2015-10-20

Review 5.  The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.

Authors:  Stephen R Armstrong; Hong Wu; Benfan Wang; Yasser Abuetabh; Consolato Sergi; Roger P Leng
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

Review 6.  ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition.

Authors:  Andrew J Stacy; Michael P Craig; Suraj Sakaram; Madhavi Kadakia
Journal:  Oncotarget       Date:  2017-01-10

Review 7.  TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development.

Authors:  Mei Yi; Yixin Tan; Li Wang; Jing Cai; Xiaoling Li; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Xiayu Li; Pingqing Tan; Bo Xiang
Journal:  Cell Mol Life Sci       Date:  2020-05-23       Impact factor: 9.261

Review 8.  Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response.

Authors:  Nicholas A Mathieu; Rafael H Levin; Donald E Spratt
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

9.  Bispecific antibodies come to the aid of cancer immunotherapy.

Authors:  Ivano Amelio; Gerry Melino; Arnold J Levine
Journal:  Mol Oncol       Date:  2021-05-14       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.